5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction

J Biol Chem. 2007 Mar 16;282(11):8052-9. doi: 10.1074/jbc.M610621200. Epub 2007 Jan 22.

Abstract

5-fluorouracil (5-FU) is a widely used chemotherapeutic drug for the treatment of a variety of solid tumors. The anti-tumor activity of 5-FU has been attributed in part to its ability to induce p53-dependent cell growth arrest and apoptosis. However, the molecular mechanisms underlying p53 activation by 5-FU remain largely obscure. Here we report that 5-FU treatment leads to p53 stabilization and activation by blocking MDM2 feedback inhibition through ribosomal proteins. 5-FU treatment increased the fraction of ribosome-free L5, L11, and L23 ribosomal proteins and their interaction with MDM2, leading to p53 activation and G1/S arrest. Conversely, individual knockdown of these ribosomal proteins by small interfering RNA prevented the 5-FU-induced p53 activation and reversed the 5-FU-induced G1/S arrest. These results demonstrate that 5-FU treatment triggers a ribosomal stress response so that ribosomal proteins L5, L11, and L23 are released from ribosome to activate p53 by ablating the MDM2-p53 feedback circuit.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology
  • Apoptosis
  • Cell Line, Tumor
  • Fluorouracil / pharmacology*
  • G1 Phase
  • Humans
  • Mitochondrial Proteins / metabolism
  • Models, Biological
  • Protein Binding
  • Proto-Oncogene Proteins c-mdm2 / chemistry*
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • RNA-Binding Proteins
  • Ribosomal Proteins / metabolism
  • Ribosomes / chemistry*
  • S Phase
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Antimetabolites, Antineoplastic
  • MRPL23 protein, human
  • Mitochondrial Proteins
  • RNA-Binding Proteins
  • Ribosomal Proteins
  • Tumor Suppressor Protein p53
  • ribosomal protein L11
  • ribosomal protein L5
  • Proto-Oncogene Proteins c-mdm2
  • Fluorouracil